|Cost Of Revenue||741.1MM||+3%|
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Thanks to the “graying of America” trend, elder care stocks may be a great opportunity for long-term investors. Even as life expectancy rates, especially for men, are falling in the United States (due to a variety of factors), the number of Americans aged 65 keeps rising, as the “Baby Boomer” generation (born between 1946 and 1964) completes entering this age range. Many industries are affected (both positively and negatively) by this demographic shift, but for certain industries, like senior li
I recently saw an article in The New York Times about the rising costs of elder care. These reports of financial ruin have become all too common in the U.S. The same goes for Canada, where I live. Only the very wealthiest are growing old with dignity. The rest of us are left to cope as best we can. Sadly, long-term care stocks are benefiting from the crisis. My task is to find three long-term care stocks to buy that are attempting to do good while remaining for-profit enterprises. That’s no easy
Ensign Group's (NASDAQ:ENSG) stock is up by a considerable 12% over the past month. Given that the market rewards...
Director Daren Shaw has recently made a significant move in the stock market by selling 2,000 shares of Ensign Group Inc (NASDAQ:ENSG), a key player in the healthcare services industry.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Henry Schein's (HSIC) third-quarter 2023 performance demonstrates remarkable sales growth in the Technology and Value-Added Service businesses.
National Vision's (EYE) higher SG&A expenses in the third quarter reflect increases in performance-based incentives and stock-based compensations.
Illumina (ILMN) reports solid earnings in the third quarter of 2023 amid a challenging macro environment.
Phibro's (PAHC) fiscal 2024 first-quarter performance reflects reduced sales in Mineral Nutrition and Performance Products.